NUTRACEUTICALS : A NEW ERA OF MEDICATION
DOI:
https://doi.org/10.61280/tjpls.v10i2.121Keywords:
Nutraceuticals, Pharmafoods, Medifoods, Vitafoods, Medicinal foodsAbstract
Abstract:- One of the most important healthcare challenges in the world today is neurological disorders.Nutraceuticals are substances derived from food that are thought to be good for human health. It is crucial for controlling brain physiology, preventing neurodegeneration, and maintaining cognitive function. Given how commonly used they are for enhancing health status, nutraceuticals have recently attracted the attention of numerous scientists. especially for the avoidance or minimization of side effects in the prevention and treatment of various neurological diseases or disorders.A number of studies on functional foods have been started recently in an effort to develop foods with higher therapeutic activity and fewer adverse effects. As a result, terminology like "pharmafoods," "medifoods," "vitafoods," and "medicinal foods" have influenced the definition of the phrase "functional foods." With a focus on clinical studies, the current study aimed to assemble all popular (major) nutraceuticals used to treat various neurodegenerative diseases (NDDs), such as Parkinson's disease (PD), Alzheimer's disease (AD), and Huntington's disease (HD). Nutraceuticals have been suggested as a preventative treatment for neurological treatments as a result of a relationship between dietary habits and lifestyle and neurodegeneration. Nutraceuticals have exhibited a variety of neuroprotective qualities, including the ability to reduce inflammation, oxidative stress, intracellular calcium excess, and mitochondrial dysfunction, acting at several biochemical and metabolic levels. These food-based methods are thought to target several pathways in a slow, more physiological way without having a significant negative impact.The most prevalent neurological movement condition in the world, Parkinson's disease (PD), is currently treated with pharmacological methods that are mostly symptomatic and frequently have unfavourable side effects.Nutraceuticals are substances obtained from whole-food sources that have therapeutic value. Their development has made it possible to use alternative methods to treat neurodegenerative disorders like Parkinson's disease. We will look at some of the significant efforts made to better understand the role of nutraceuticals in PD in this study. This study will help regular people choose better nutritional supplements, combined with traditional neuroprotective medications and altered lifestyle habits, to battle various NDDs.
Downloads
References
Raymond, A. C. Roos. Huntington disease: a clinical review. Roos Orphanet J Rare Dis. 2010, 3, 5-40.
Beal, M. F. Mitochondria take center stage in aging and neurodegeneration. Ann. Neurol.
, 58, 247-254.
Nicklas, W. J.; Vyas, I.; Heikkilia, R. E. Inhibition of NADH-linked oxidation in brain mito-
chondria by 1-methyl-4- phenyl-pyridine, a metabolite of the neurotoxin, 1-methyl-4-phenyl-1, 1, 5, 6-teterhydropyridine. Life Sci. 1985, 36, 2503-2508.
Tang, T. S.; Slow, E.; Lupu, V.; Stavrovskaya, I. G.; Sugimori, M.; Llinas, R.; Kristal, B. S.;
Hayden, M. R.; Bezprozvanny, I. Disturbed Ca2+signaling and apoptosis of medium spiny neu-
rons in huntington’s disease. Proc. Natl. Acad. Sci. USA. 2005, 102, 2602-2607.
Gu, M.; Gash, M. T.; Mann, V. M.; Javoy-Agid, F.; Copper, J. M.; Schapira, A. H. Mitochon-
drial defect in huntington’s disease caudate nucleus. Ann. Neurol. 1996, 39, 385-389.
. Schalaepfer, W. W.; Bunge, R. P. Effects of calcium ion concentration on the degeneration of
amputated axons in tissue culture. J. Cell. Biol. 1973, 59, 456-470.
Celsi, F.; Pizzo, P.; Brini, M.; Leo, S.; Fotino, C.; Pinton, P.; Rizzuto, R. Mitochondria, cal-
cium and cell death: a deadly triad in neurodegeneration. Biochim. Biophys Acta. 2009, 1787,
–344.
Zündorf, G.; Reiser, G. Calcium dysregulation and homeostasis of neural calcium in the
molecular mechanisms of neurodegenerative diseases provide multiple targets for neuroprotec-
tion. Antioxid. Redox. Signal. 2011, 14, 1275– 1288.
Chan, C. S.; Gertler, T. S.; Surmeier, D. J. Calcium homeostasis, selective vulnerability and
Parkinson’s disease. Trends Neurosci. 2009, 32, 249–256.
Lim, D.; Fedrizzi, L.; Tartari, M.; Zuccato, C.; Cattaneo, E.; Brini, M.; Carafoli, E. Calcium
homeostasis and mitochondrial dysfunction in striatal neurons of Huntington disease. J. Biol.
Chem. 2008, 283, 5780–5789.
Betteridge, D. J. What is oxidative stress? Metabolism. 2000, 49, Suppl. 1, 3–8.
Hensley, K.; Butterfield, D. A.; Hall, N.; Cole, P., Subramaniam, R.; Mark, R.; Mattson, M.
P.; Markesbery, W. R.; Harris, M. E.; Aksenov, M. Reactive oxygen species as causal agents in
the neurotoxicity of the Alzheimer’s disease- associated amyloid beta peptide. Ann. N. Y. Acad
Sci. 1996, 786, 120–134.
Napolitano, A.; Crescenzi, O.; Pezzella, A.; Prota, G. Generation of the neurotoxin 6-hy-
droxydopamine by peroxidase/H2 O2 oxidation of dopamine. J. Med. Chem. 1995, 38, 917–922.
Pedersen, W. A.; Fu, W.; Keller, J. N.; Markesbery, W. R.; Appel, S.; Smith, R. G.; Kasarskis,
E.; Mattson, M. P. Protein modification by the lipid peroxidation product 4-hydroxynonenal
in the spinal cords of amyotrophic lateral sclerosis patients. Ann. Neurol. 1998, 44, 819–824.
. Goebel, H. H.; Heipertz, R.; Scholz, W.; Iqbal, K.; Tellez-Nagel, I. Juvenile Huntington cho-
rea: clinical, ultrastructural, and biochemical studies. Neurol. 1978, 28, 23–31.
Gendelman, H. E. Neural immunity: Friend or foe? J. Neurovirol. 2002, 8, 474–479.
Bal-Price, A.; Matthias, A.; Brown, G. C. Stimulation of the NADPH oxidase in activated rat
microglia removes nitric oxide but induces peroxynitrite production. J. Neurochem. 2002,
Bass IS and Young AL. Dietary Supplement Health and Education Act. The Food and Drug Law Institute, Washington DC, 1996.
Scarlett T. How modernized is FDA now? FDLI Update. 3:1, 1998.
Ohama H, Ikeda H and Moriyama H. Health foods and Foods with health claims in Japan. Toxicology. 2006;221:95-111
Hathcock J. Dietary supplements: How they are used and regulated. J. Nutrition. 2001; 131:
Published
How to Cite
Issue
Section
Copyright (c) 2023 Tropical Journal of Pharmaceutical and Life Sciences
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
